Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Scotia set CXR target price US$75 and rated outperformance
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by grox01on Feb 10, 2016 2:38pm
93 Views
Post# 24544667

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Scotia set CXR target price US$75 and rated outperformance

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Scotia set CXR target price US$75 and rated outperformanceIt seems many here do read to much of the ups and downs of every days, hours, minutes of the stock price. Those that do... they will often trade to much.
If you go the investment's way... just tune in every quarter to look at the facts, the real numbers and stay far from the noise that you keep reading here.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities